Full-Time

Director – Clinical Data Management Systems and Standards

Posted on 9/12/2024

Cytokinetics

Cytokinetics

501-1,000 employees

Develops drugs for muscle function disorders

Biotechnology
Healthcare

Compensation Overview

$225k - $275kAnnually

Senior, Expert

San Bruno, CA, USA

Category
Data Management
Data Engineering
Data & Analytics
Requirements
  • Bachelor’s degree in life sciences (e.g. biology), data science, computer science, statistics, etc. or equivalent combination of a bachelor’s degree and relevant job experience. Graduate degree is preferred but not required
  • At least 15 years of relevant data management experience and at least 5 years of managerial experience leading CDM teams in the biotech, pharmaceutical, medical device or CRO industry, including experience in multiple therapeutic areas and in various phases of drug development.
  • Prior experience managing EDC systems (Medidata Rave preferred) trial infrastructure setup & deployment as well as leading CDM process development and improvement
  • Prior management experience in clinical trial data collection systems (EDC, eCOA, CTMS, Drug Safety Database Systems, IWRS/RTSM, reporting tools, data visualization, etc.) and practical knowledge of data integration between data collection systems
  • Detailed knowledge of data standards (CDISC, CDASH, SDTM) in the clinical environment
  • In depth knowledge of clinical data management in the Biotech, Pharmaceutical or CRO industry. Competence in data programming (e.g. SAS, BI / analytics tools, EDC Programming) required
  • Demonstrated leadership quality and superior organizational and interpersonal skills. Excellent written and verbal communication skills
  • Knowledge of the current industry best practices, FDA and ICH regulations, ICH-GCP, GCDMP and other applicable local and international regulations
Responsibilities
  • Serve as the inter-department subject matter expert for EDC platforms (e.g. Medidata) including management of the environment as well as the standards library to enable planning, coordination, and timely delivery of complete, high quality and reliable clinical trial data for internal decision-making, regulatory approval, and market acceptance
  • Develop and ensure compliance from a CDM / EDC and data programming perspective including the development of SOPs and standardization of operational and technical methodologies
  • Oversee CDM and data visualization programming functions. Develop the infrastructure, people, standards, and processes to build out this capability within the Cytokinetics CDM department
  • Ensure the continued development, review and maintenance of SOPs and process documentation in accordance with corporate, industry and regulatory agency standards
  • Provide strategic, organizational, and operational management and guidance to the personnel and teams within the system and standards team, as required
  • Provide technical and functional oversight of the day-to-day use of CDM systems and related processes, as needed, including EDC build standards, clinical data collection, processing, system integrations, and quality control procedures, timelines, and documentation
  • Lead the evaluation and selection of future CDM systems infrastructure and solutions including clinical programming and data visualization tools, eSAE, data lake/warehouse Clinical Data Repository solutions, and AI/machine learning
  • Develop and maintain the infrastructure, organization, and processes to manage and oversee EDC and other systems programming and development timelines including metrics to track the quality and efficiency of build and development timelines.
  • Assist with the selection and management of data management vendors; identify potential risks and resolving issues with systems vendors and CROs; oversee vendor management plans and reviewing quality metrics; provides guidance and monitors the progress of DM activities with CROs or other vendors
  • Contribute to identifying, locating, evaluating, and validating CDM documents, databases, and integrations required for report generation or regulatory submission
  • Assist with the coordination of non-routine projects as applicable in support of Development Operations initiatives
  • Assist with leading clinical study programs as required to support company goals and objectives
  • Collaborate with cross functional peers to facilitate and optimize the product development and registration process

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a range of drugs in clinical trials, including omecamtiv mecarbil and reldesemtiv, aimed at treating conditions like heart failure, ALS, and HCM. What sets Cytokinetics apart from competitors is its dedicated focus on muscle-related diseases and its extensive pipeline of potential treatments. The goal of Cytokinetics is to bring effective therapies to market that address the unmet medical needs of patients suffering from debilitating muscle conditions.

Company Stage

IPO

Total Funding

$58.4M

Headquarters

South San Francisco, California

Founded

1998

Growth & Insights
Headcount

6 month growth

2%

1 year growth

1%

2 year growth

14%
Simplify Jobs

Simplify's Take

What believers are saying

  • Cytokinetics secured $575M funding from Royalty Pharma for R&D and commercial launch.
  • Positive Phase III results for aficamten in treating obstructive hypertrophic cardiomyopathy.
  • Increased investment interest, with $1.73M from Intech and $1.88M from Bridger Management.

What critics are saying

  • Competition from Bristol-Myers Squibb's Camzyos in hypertrophic cardiomyopathy market.
  • Reliance on successful clinical trial outcomes for financial stability.
  • Need for substantial capital, indicated by recent public offering and external funding.

What makes Cytokinetics unique

  • Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.
  • The company targets niche markets like hypertrophic cardiomyopathy and amyotrophic lateral sclerosis.
  • Cytokinetics has a robust pipeline including omecamtiv mecarbil and aficamten.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE